219 related articles for article (PubMed ID: 17942559)
21. Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV.
Jahan S; Khaliq S; Samreen B; Ijaz B; Khan M; Ahmad W; Ashfaq UA; Hassan S
Virol J; 2011 Jun; 8():295. PubMed ID: 21663667
[TBL] [Abstract][Full Text] [Related]
22. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus infection of neuroepithelioma cell lines.
Fletcher NF; Yang JP; Farquhar MJ; Hu K; Davis C; He Q; Dowd K; Ray SC; Krieger SE; Neyts J; Baumert TF; Balfe P; McKeating JA; Wong-Staal F
Gastroenterology; 2010 Oct; 139(4):1365-74. PubMed ID: 20538002
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.
Hsu M; Zhang J; Flint M; Logvinoff C; Cheng-Mayer C; Rice CM; McKeating JA
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7271-6. PubMed ID: 12761383
[TBL] [Abstract][Full Text] [Related]
25. Novel function of CD81 in controlling hepatitis C virus replication.
Zhang YY; Zhang BH; Ishii K; Liang TJ
J Virol; 2010 Apr; 84(7):3396-407. PubMed ID: 20089661
[TBL] [Abstract][Full Text] [Related]
26. CD81 is an entry coreceptor for hepatitis C virus.
Cormier EG; Tsamis F; Kajumo F; Durso RJ; Gardner JP; Dragic T
Proc Natl Acad Sci U S A; 2004 May; 101(19):7270-4. PubMed ID: 15123813
[TBL] [Abstract][Full Text] [Related]
27. CD81 engineered with endocytotic signals mediates HCV cell entry: implications for receptor usage by HCV in vivo.
Tan YJ; Lim SP; Ng P; Goh PY; Lim SG; Tan YH; Hong W
Virology; 2003 Apr; 308(2):250-69. PubMed ID: 12706076
[TBL] [Abstract][Full Text] [Related]
28. Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization.
Deest M; Westhaus S; Steinmann E; Manns MP; von Hahn T; Ciesek S
Antiviral Res; 2014 Jan; 101():37-44. PubMed ID: 24211330
[TBL] [Abstract][Full Text] [Related]
29. EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry.
Potel J; Rassam P; Montpellier C; Kaestner L; Werkmeister E; Tews BA; Couturier C; Popescu CI; Baumert TF; Rubinstein E; Dubuisson J; Milhiet PE; Cocquerel L
Cell Microbiol; 2013 Jul; 15(7):1234-52. PubMed ID: 23351194
[TBL] [Abstract][Full Text] [Related]
30. The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus.
Meertens L; Bertaux C; Cukierman L; Cormier E; Lavillette D; Cosset FL; Dragic T
J Virol; 2008 Apr; 82(7):3555-60. PubMed ID: 18234789
[TBL] [Abstract][Full Text] [Related]
31. Identification of transferrin receptor 1 as a hepatitis C virus entry factor.
Martin DN; Uprichard SL
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10777-82. PubMed ID: 23754414
[TBL] [Abstract][Full Text] [Related]
32. Significance of palmitoylation of CD81 on its association with tetraspanin-enriched microdomains and mediating hepatitis C virus cell entry.
Zhu YZ; Luo Y; Cao MM; Liu Y; Liu XQ; Wang W; Wu DG; Guan M; Xu QQ; Ren H; Zhao P; Qi ZT
Virology; 2012 Aug; 429(2):112-23. PubMed ID: 22560863
[TBL] [Abstract][Full Text] [Related]
33. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.
Triyatni M; Vergalla J; Davis AR; Hadlock KG; Foung SK; Liang TJ
Virology; 2002 Jun; 298(1):124-32. PubMed ID: 12093180
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus receptor expression in normal and diseased liver tissue.
Reynolds GM; Harris HJ; Jennings A; Hu K; Grove J; Lalor PF; Adams DH; Balfe P; Hübscher SG; McKeating JA
Hepatology; 2008 Feb; 47(2):418-27. PubMed ID: 18085708
[TBL] [Abstract][Full Text] [Related]
35. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL
Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396
[TBL] [Abstract][Full Text] [Related]
36. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles.
Morikawa K; Zhao Z; Date T; Miyamoto M; Murayama A; Akazawa D; Tanabe J; Sone S; Wakita T
J Med Virol; 2007 Jun; 79(6):714-23. PubMed ID: 17457918
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies.
Timpe JM; Stamataki Z; Jennings A; Hu K; Farquhar MJ; Harris HJ; Schwarz A; Desombere I; Roels GL; Balfe P; McKeating JA
Hepatology; 2008 Jan; 47(1):17-24. PubMed ID: 17941058
[TBL] [Abstract][Full Text] [Related]
38. Hepatoma polarization limits CD81 and hepatitis C virus dynamics.
Harris HJ; Clerte C; Farquhar MJ; Goodall M; Hu K; Rassam P; Dosset P; Wilson GK; Balfe P; Ijzendoorn SC; Milhiet PE; McKeating JA
Cell Microbiol; 2013 Mar; 15(3):430-45. PubMed ID: 23126643
[TBL] [Abstract][Full Text] [Related]
39. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
Meola A; Sbardellati A; Bruni Ercole B; Cerretani M; Pezzanera M; Ceccacci A; Vitelli A; Levy S; Nicosia A; Traboni C; McKeating J; Scarselli E
J Virol; 2000 Jul; 74(13):5933-8. PubMed ID: 10846074
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C Virus Infection of Cultured Cells and Primary Human Hepatocytes.
Lowey B; Li Q
Curr Protoc Cell Biol; 2018 Sep; 80(1):e54. PubMed ID: 30058773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
